The Complementary Medicine Association was one of the largest and longest established single modality associations in Australia, being founded in 1985. The vision and purpose was to dedicate themselves to representing professional Naturopaths to Government bodies, Health Funds, Insurance Companies and the General Public.
As of January 2013 however, in a bold move away from its ‘single modality status’ the CMA decided to alter its acceptance criteria to not only those studying in and (duly) qualified in Naturopathy, but also; Homeopathy, Nutrition, Western Herbal Medicine, Chinese Herbal Medicine and Ayurveda.
The CMA Board of Directors decided it was time to grow the CMA family into a larger group of like minded (ingestive modality) professionals, without losing the integrity of the Associations beliefs, constitution and direction. Thus in turn also giving the CMA and its members a bigger, stronger, more united voice and even more recognition with those departments and bodies most important to be ‘known’ by.
Some of the CMA’s main objectives are;
- To ensure members are adequately qualified to practice
- To encourage Continued Practitioner Education (CPE)
- To ensure practitioners maintain professional indemnity insurance
- To enforce a suitable code of ethics and by laws by which to abide by
- To ensure professional standards of practice and clinical amenities
- To oversee the servicing of health fund benefits to patients
- To safeguard patients’ interests wherever and however possible
- To handle patient complaints
- To represent our practitioners in the utmost professional manner
If you cannot find the information you are looking for, email us at firstname.lastname@example.org
VIEW A COPY OF THE CMA MISSION STATEMENT
(formerly the Complementary Healthcare Council)
RECENT DEPARTMENT OF HEALTH NEWS
Leading medical researchers, academics, clinicians and administrators have been appointed to the Council of the National Health and Medical Research Council (NHMRC).
Australian patients are being forced to wait up to 15 months longer to access the latest breakthrough medicines than in the US or Europe because drug companies are delaying bringing them down under, a new landmark report has revealed.
Consumers are the big winners from the Senate passing the Australian Government’s Pharmaceutical Benefits Scheme (PBS) reform package.
New figures released as part of National Bowel Cancer Awareness month show a three per cent increase during the previous year in the number of Australians returning completed bowel cancer screening kits.
The Australian Government is working hand-in-hand with the mental health sector to take the National Mental Health Commission’s landmark review from paper to policy.
The Australian Government is working towards the revival of a national approach to improving mental health outcomes and access to support services long-term.
Minister for Agriculture, Barnaby Joyce, and Assistant Minister for Health, Fiona Nash, have moved to update Australians on the situation involving imported frozen berries and Hepatitis A.
Assistant Minister for Health Fiona Nash has moved to outline actions being taken following the importation and distribution of berries which appear to have carried Hepatitis A.
Minister for Health Sussan Ley has approved a life-saving drug that will ensure young Australian Pompe patients receive treatment they previously may not have been able to access.
The Abbott Government has given pharmacists, consumers, doctors and medicines manufacturers the opportunity to present their views about the next multi-billion Community Pharmacy Agreement (CPA).
The Australian and New Zealand Governments have agreed to cease efforts to establish a joint therapeutic products regulator, the Australia New Zealand Therapeutic Products Agency (ANZTPA).
The Australian Government has announced an independent review of the regulation of medicines and medical devices.
The Federal Minister for Health, the Hon Peter Dutton, has announced that the cost of 50 new and amended medicines and technologies to treat cancer, diabetes, multiple sclerosis and a range of other debilitating diseases will be subsidised by the Government.
From April, private health insurance premiums will increase by an average of 5.6%, as the government urged families to shop around for the best deal using comparisons available on the government’s health fund website.